Salesforce (CRM) is trading lower today, down roughly 3.77% to $178.82, as the market focuses on balance-sheet risk from its debt-funded capital return plan. The company recently executed a large bond deal to fund a $25 billion accelerated share repurchase (ASR), and the renewed debate over leverage and cost of capital is weighing on sentiment toward the stock.

Salesforce priced an aggregate $25 billion senior notes offering that was earmarked for immediate repurchases via ASR transactions, and it has since begun the prepayment and initial share deliveries under those agreements (including an initial delivery of about 103 million shares). While buybacks typically support EPS and can signal confidence, the structure increases gross debt and makes the equity story more sensitive to credit spreads, rates, and any deceleration in growth or free-cash-flow conversion. (investor.salesforce.com)

Investors appear to be marking down the stock on the view that a debt-financed repurchase, even at scale, can trade like a refinancing and risk-management event rather than a growth catalyst—especially when software valuations and AI-related competitive narratives remain in flux. Recent commentary around the bond sale noted softer appetite and concerns tied to leverage and broader software exposure to AI disruption, keeping pressure on CRM on down days. (finance.yahoo.com)

Key near-term markers include how quickly the ASR reduces diluted shares outstanding beyond the initial delivery, updates to leverage/ratings outlook as the new notes season, and whether management can demonstrate re-acceleration in bookings and AI monetization without margin trade-offs. Any additional updates on financing capacity (credit agreements) or further capital return adjustments could also swing sentiment given the stock’s elevated sensitivity to balance-sheet headlines. (intellectia.ai)